Androgen receptor antagonists in castration-resistant prostate cancer

D Rathkopf, HI Scher - The Cancer Journal, 2013 - journals.lww.com
Persistent androgen receptor (AR) signaling despite low levels of serum androgens has
been identified as a critical target for drug discovery in castration-resistant prostate cancer …
被引用次数：165 相关文章

Androgen receptor antagonists in castration-resistant prostate cancer.

D Rathkopf, HI Scher - Cancer Journal (Sudbury, Mass.), 2013 - europepmc.org
Persistent androgen receptor signaling despite low levels of serum androgens has been
identified as a critical target for drug discovery in castration-resistant prostate cancer. As …
[HTML] nih.gov

[HTML][HTML] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer

D Rathkopf, HI Scher - Cancer journal (Sudbury, Mass.), 2013 - ncbi.nlm.nih.gov
Persistent androgen receptor signaling despite low levels of serum androgens has been
identified as a critical target for drug discovery in castration-resistant prostate cancer. As …

Androgen receptor antagonists in castration-resistant prostate cancer

D Rathkopf, HI Scher - Cancer journal (Sudbury, Mass.), 2013 - pubmed.ncbi.nlm.nih.gov
Persistent androgen receptor (AR) signaling despite low levels of serum androgens has
been identified as a critical target for drug discovery in castration-resistant prostate cancer …

[引用][C] Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer

D Rathkopf, HI Scher - The Cancer Journal, 2013 - cir.nii.ac.jp
Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Androgen receptor antagonists in castration-resistant prostate cancer.

D Rathkopf, HI Scher - Cancer Journal (Sudbury, Mass.), 2013 - europepmc.org
Persistent androgen receptor signaling despite low levels of serum androgens has been
identified as a critical target for drug discovery in castration-resistant prostate cancer. As …